SCHEMBL4933340

SCHEMBL4933340

ClCCN(CCCl)Cc1ccc(Nc2c3ccccc3nc3ccccc23)cc1

nearest known ligand 0.57

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KDM1A O60341 10/20 0.57
HDAC3 O15379 2/20 0.53
HDAC4 P56524 2/20 0.53
HDAC1 Q13547 2/20 0.53
HDAC7 Q8WUI4 2/20 0.53
HDAC2 Q92769 2/20 0.53
HDAC8 Q9BY41 2/20 0.53
HDAC6 Q9UBN7 2/20 0.53
HDAC9 Q9UKV0 2/20 0.53
HDAC5 Q9UQL6 2/20 0.53
KMT2A Q03164 3/20 0.50
POLB P06746 2/20 0.50
RAD52 P43351 2/20 0.50
KDM4E B2RXH2 2/20 0.50
MAPT P10636 2/20 0.50
NPSR1 Q6W5P4 2/20 0.50
OPRM1 P35372 1/20 0.50
OPRD1 P41143 1/20 0.50
L3MBTL1 Q9Y468 1/20 0.50
GFER P55789 1/20 0.50

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4936550 0.85 TOP2A (0.64) KDM1AHDAC4HDAC7HDAC6HDAC9
SCHEMBL17154456 0.82 KDM1A (0.70) KDM1AKMT2APOLBRAD52KDM4E
SCHEMBL17423360 0.81 KDM1A (0.66) KDM1AHDAC3HDAC4HDAC1HDAC7
SCHEMBL4941215 0.81 KMT2A (0.61) KDM1AKMT2APOLBRAD52KDM4E
SCHEMBL17154457 0.80 KDM1A (0.59) KDM1AKMT2APOLBRAD52KDM4E
SCHEMBL4948317 0.79 POLB (0.58) KDM1AKMT2APOLBRAD52KDM4E
SCHEMBL17154429 0.77 KDM1A (0.64) KDM1AHDAC3HDAC4HDAC1HDAC7
SCHEMBL8006566 0.76 TOP2A (0.70) KDM1AHDAC3HDAC4HDAC1HDAC7
SCHEMBL902770 0.75 KDM1A (1.00) KDM1AHDAC3HDAC4HDAC1HDAC7
SCHEMBL15673265 0.74 KDM1A (0.75) KDM1AKMT2APOLBRAD52GFER

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20080176889-A1 9-anilinoacridine alkylating agents ACADEMIA SINICA (TW) 2008-07-24 US disclosed
US-20080176889-A1 9-anilinoacridine alkylating agents ACADEMIA SINICA (TW) 2008-07-24 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20080176889-A1 9-anilinoacridine alkylating agents BCL9, MCL1, BCL9L KDM1A 1168/4885HDAC3 473/4885HDAC4 698/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.